Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $106.48 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $26.33 | 2 | $0 (2018) |
| Rhodes Pharmaceuticals L.P. | $19.01 | 1 | $0 (2018) |
| Mission Pharmacal Company | $18.94 | 1 | $0 (2017) |
| Neos Therapeutics, LP | $18.23 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $13.65 | 1 | $0 (2017) |
| Mylan Specialty L.P. | $10.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $50.39 | 3 | Rhodes Pharmaceuticals L.P. ($19.01) |
| 2017 | $56.09 | 4 | Mission Pharmacal Company ($18.94) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: DERMATOLOGY | ||||||
| 08/01/2018 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: ADHD | ||||||
| 02/20/2018 | Rhodes Pharmaceuticals L.P. | Aptensio XR (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Neurology | ||||||
| 10/10/2017 | Mylan Specialty L.P. | Dymista (Drug), Epinephrine, EpiPen | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Respiratory and Allergy | ||||||
| 09/20/2017 | AstraZeneca Pharmaceuticals LP | SYNAGIS (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Respiratory | ||||||
| 08/11/2017 | Mission Pharmacal Company | Prednisolone 25 (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Adrenocorticosteroid | ||||||
| 03/23/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: DERMATOLOGY | ||||||
About Dr. Mark Simpson, MD
Dr. Mark Simpson, MD is a Pediatrics healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922048966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Simpson, MD has received a total of $106.48 in payments from pharmaceutical and medical device companies, with $50.39 received in 2018. These payments were reported across 7 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($106.48).
Practice Information
- Specialty Pediatrics
- Location Cary, NC
- Active Since 06/07/2006
- Last Updated 01/26/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1922048966
Products in Payments
- EUCRISA (Drug) $26.33
- Aptensio XR (Drug) $19.01
- Prednisolone 25 (Drug) $18.94
- Cotempla XR-ODT (Drug) $18.23
- SYNAGIS (Biological) $13.65
- Dymista (Drug) $10.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Cary
Christine Macomber, Md, MD
Pediatrics — Payments: $2,652
Mrs. Kara Willette, Aprn; Pnp, APRN; PNP
Pediatrics — Payments: $1,304
Jessica Pulling, Pnp, PNP
Pediatrics — Payments: $1,290
Dr. Raveendra Orugunta, M.d, M.D
Pediatrics — Payments: $1,045
Ramadevi Nanga, M.d, M.D
Pediatrics — Payments: $1,032
Kristin Donoghue, Md, MD
Pediatrics — Payments: $977.85